The FDA on Wednesday issued an emergency use authorization for Novavax's COVID-19 vaccine for adults 18 and older.
UPDATED 6:05 PM ET Jul. 13, 2022The Food and Drug Administration on Wednesday issued an emergency use authorization for Novavax's COVID-19 vaccine for adults 18 and older, giving Americans an additional option to choose from to get vaccinated against the deadly coronavirus.
Novavax makes a more traditional type of shot than the three other COVID-19 vaccines available for use in the U.S. Novavax CEO Stanley Erck told The Associated Press that he expected the U.S. to expand use of the vaccine beyond unvaccinated adults fairly quickly. The Novavax vaccine is made of copies of the spike protein that coats the coronavirus, packaged into nanoparticles that to the immune system resemble a virus. Then an immune-boosting ingredient, or adjuvant, that’s made from the bark of a South American tree is added that acts as a red flag to ensure those particles look suspicious enough to spark a strong immune response.
The Novavax vaccine was tested long before the omicron variant struck. But last month, the company released data showing a booster dose promised a strong immune response even against omicron’s newest relatives — preliminary evidence that several of the FDA’s scientific advisers called compelling.
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Novavax COVID-19 vaccine: FDA authorizes fourth shot for adultsNovavax makes a more traditional type of shot than the three other COVID-19 vaccines available for use in the U.S. -- and one that’s already available in Europe and multiple other countries.
Read more »
Novavax Covid-19 vaccine wins FDA authorizationThe FDA granted emergency use authorization to Novavax’s Covid-19 vaccine. In a trial of more than 26,000 adults, 2 doses of the Novavax Covid vaccine were over 90% effective at preventing symptomatic disease and presented no serious side effects.
Read more »
US regulators OK new COVID-19 shot option from NovavaxThe U.S. is getting another COVID-19 vaccine choice
Read more »
US regulators OK new COVID-19 shot option from NovavaxNovavax makes a more traditional type of shot than the three other COVID-19 vaccines available for use in the U.S.
Read more »
U.S. health officials approve new COVID-19 shot from NovavaxThe U.S. is getting another COVID-19 vaccine choice as the Food and Drug Administration on Wednesday cleared Novavax shots for adults. Novavax makes a more...
Read more »